Tempus Wealth Planning LLC Acquires 2,576 Shares of Haleon plc (NYSE:HLN)

Tempus Wealth Planning LLC increased its stake in shares of Haleon plc (NYSE:HLN) by 4.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 57,389 shares of the company’s stock after acquiring an additional 2,576 shares during the quarter. Tempus Wealth Planning LLC’s holdings in Haleon were worth $474,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Cardinal Capital Management increased its holdings in shares of Haleon by 2.5% during the 2nd quarter. Cardinal Capital Management now owns 46,231 shares of the company’s stock worth $382,000 after purchasing an additional 1,140 shares during the period. Portside Wealth Group LLC lifted its position in shares of Haleon by 2.7% in the 2nd quarter. Portside Wealth Group LLC now owns 44,985 shares of the company’s stock worth $372,000 after acquiring an additional 1,182 shares during the period. Pinnacle Bancorp Inc. grew its holdings in shares of Haleon by 29.8% during the 1st quarter. Pinnacle Bancorp Inc. now owns 6,188 shares of the company’s stock worth $53,000 after purchasing an additional 1,421 shares in the last quarter. Blue Barn Wealth LLC increased its position in shares of Haleon by 7.3% during the fourth quarter. Blue Barn Wealth LLC now owns 20,858 shares of the company’s stock valued at $172,000 after purchasing an additional 1,425 shares during the period. Finally, First Horizon Advisors Inc. raised its stake in shares of Haleon by 11.6% in the second quarter. First Horizon Advisors Inc. now owns 15,104 shares of the company’s stock valued at $125,000 after purchasing an additional 1,568 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have weighed in on HLN shares. Berenberg Bank began coverage on shares of Haleon in a research note on Tuesday, August 6th. They set a “buy” rating on the stock. The Goldman Sachs Group lowered shares of Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, Haleon presently has an average rating of “Moderate Buy”.

Haleon Price Performance

Shares of NYSE HLN traded up $0.02 during midday trading on Friday, reaching $9.90. 2,997,390 shares of the company traded hands, compared to its average volume of 5,124,313. Haleon plc has a 12 month low of $7.70 and a 12 month high of $9.94. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.73 and a current ratio of 1.04. The stock’s 50-day simple moving average is $9.04 and its 200-day simple moving average is $8.59. The firm has a market cap of $45.20 billion, a PE ratio of 33.00, a PEG ratio of 2.69 and a beta of 0.24.

Haleon (NYSE:HLN) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). Haleon had a net margin of 9.71% and a return on equity of 19.85%. The business had revenue of $3.50 billion during the quarter, compared to the consensus estimate of $3.55 billion. During the same quarter in the previous year, the firm posted $0.08 EPS. As a group, equities analysts anticipate that Haleon plc will post 0.47 earnings per share for the current fiscal year.

Haleon Cuts Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 19th. Investors of record on Friday, August 16th will be given a $0.0514 dividend. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, August 16th. Haleon’s dividend payout ratio (DPR) is presently 33.33%.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.